Skip to content
Menu

Assembly Biosciences Q1 EPS $(0.54) Beats $(0.71) Estimate, Sales $8.213M Miss $9.266M Estimate

Benzinga Newsdesk 6 months ago

EarningsEarnings BeatsEarnings MissesNews

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.71) by 23.94 percent. This is a 53.85 percent increase over losses of $(1.17) per share

Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.71) by 23.94 percent. This is a 53.85 percent increase over losses of $(1.17) per share from the same period last year. The company reported quarterly sales of $8.213 million which missed the analyst consensus estimate of $9.266 million by 11.36 percent. This is a 12.80 percent decrease over sales of $9.419 million the same period last year.

Read at benzinga.com